DBVTDBV Technologies S.A.

$538M

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+18.0% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$44M-2307.3% margin

Net Income

-$45M-2346.8% margin

EPS (Diluted)

$-9.05

QoQ Revenue Growth

+1.5%

Cash Flow

Operating Cash Flow

-$35M

Free Cash Flow

-$37M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$250M

Total Liabilities

$67M

Stockholders' Equity

$183M

Cash & Equivalents

$194M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	+18.0%
Gross Profit	$2M	$930,954	+106.3%
Operating Income	-$44M	-$35M	-26.3%
Net Income	-$45M	-$34M	-31.6%

DBVT Q4 2017 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena